社区药房对于早期发现老年人认知障碍的有用性,使用IQ-CODE问卷
L F Agüera Ortiz1, G García-Ribas, F Jordano Luna
1Dr. Begoña Soler López, Medical Director, E-C-BIO, S.L., c/ Rosa de Lima, 1, Edificio ALBA, Office 016; 28230 - Las Rozas (Madrid) Spain. Tel: +34 91 630 04 80; Fax: +34 91 858 29 00; Mobile: +34 607 56 42 45, Email: bsoler@ecbio.net, ORCID: 0000-0001-5853-2307.
The journal of prevention of Alzheimer's disease
|June 25, 2023
概括
社区药房可以帮助早期发现老年人的认知障碍 (CI). 这项研究发现,38.5%的70岁以上的人有风险,记忆力损失等因素增加了这种风险.
科学领域:
- 老年学是一门学科.
- 公共卫生 公共卫生
- 临床药房 临床药房
背景情况:
- 早期识别认知障碍 (CI) 对于防止发展为痴呆症至关重要.
- 社区药房为老年人群中早期IC检测提供了一个潜在的环境.
研究的目的:
- 评估社区药房在使用护理人员报告的老年人CI早期检测中的有效性.
- 为了确定与老年人认知衰退 (IQ-CODE) 信息人问卷相关的风险因素分类.
主要方法:
- 在西班牙社区药房进行了一项横截面观察研究.
- 药剂师招募了70岁以上没有诊断CI的个体的护理人员.
- 由护理人员填写的IQ-CODE问卷评估了CI的风险.
主要成果:
- 在910名参与者中,38.5%的70岁以上的人被归类为"有CI风险".
- 患CI的风险随着年龄的增长而增加,并且与记忆障碍 (4.3倍),最近中风 (2.5倍),吸烟 (1.9倍) 和糖尿病 (1.6倍) 有显著关联.
结论:
- 社区药房可以有效地帮助早期发现认知障碍.
- 在药店中发现的CI风险的流行程度与初级保健数据一致,验证了这一方法.
更多相关视频
相关概念视频
Intellectual Disability
120
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
120
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
163
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
163
Integrated Healthcare System
1.7K
An integrated healthcare system (IHS) is a set of organizations that provides for or arranges to provide coordinated and continuous service to a defined population. The IHS takes responsibility for that particular population's health status and outcome, both clinically and fiscally. An integrated healthcare system is a well-organized, well-coordinated, and collaborative network. The integrated delivery system is a network that connects different healthcare providers to deliver organized,...
1.7K
Alzheimer's Disease: Treatment
222
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
222
Cognitive Development During Adulthood
160
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
160
Alzheimer's Disease: Overview
530
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
530


